Capuano C - Search Results

1

Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions.

Capuano C, De Federicis D, Ciuti D, Turriziani O, Angeloni A, Anastasi E, Giannini G, Belardinilli F, Molfetta R, Alvaro D, Palmieri G, Galandrini R. Capuano C, et al. Front Immunol. 2023 Nov 16;14:1285203. doi: 10.3389/fimmu.2023.1285203. eCollection 2023. Front Immunol. 2023. PMID: 38045702 Free PMC article.

2

Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming.

Capuano C, Battella S, Pighi C, Franchitti L, Turriziani O, Morrone S, Santoni A, Galandrini R, Palmieri G. Capuano C, et al. Front Immunol. 2018 May 11;9:1031. doi: 10.3389/fimmu.2018.01031. eCollection 2018. Front Immunol. 2018. PMID: 29867997 Free PMC article.

3

Activation of Lymphocyte Cytolytic Machinery: Where are We?

Galandrini R, Capuano C, Santoni A. Galandrini R, et al. Among authors: capuano c. Front Immunol. 2013 Nov 19;4:390. doi: 10.3389/fimmu.2013.00390. Front Immunol. 2013. PMID: 24312097 Free PMC article. Review.

4

c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells.

Molfetta R, Quatrini L, Capuano C, Gasparrini F, Zitti B, Zingoni A, Galandrini R, Santoni A, Paolini R. Molfetta R, et al. Among authors: capuano c. Eur J Immunol. 2014 Sep;44(9):2761-70. doi: 10.1002/eji.201444512. Epub 2014 Jun 17. Eur J Immunol. 2014. PMID: 24846123 Free article.

5

Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells.

Capuano C, Romanelli M, Pighi C, Cimino G, Rago A, Molfetta R, Paolini R, Santoni A, Galandrini R. Capuano C, et al. Cancer Res. 2015 Oct 1;75(19):4097-108. doi: 10.1158/0008-5472.CAN-15-0781. Epub 2015 Jul 30. Cancer Res. 2015. PMID: 26229120

6

Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production.

Capuano C, Pighi C, Molfetta R, Paolini R, Battella S, Palmieri G, Giannini G, Belardinilli F, Santoni A, Galandrini R. Capuano C, et al. Oncoimmunology. 2017 Feb 10;6(3):e1290037. doi: 10.1080/2162402X.2017.1290037. eCollection 2017. Oncoimmunology. 2017. PMID: 28405525 Free PMC article.

7

Memory NK Cell Features Exploitable in Anticancer Immunotherapy.

Capuano C, Pighi C, Battella S, Santoni A, Palmieri G, Galandrini R. Capuano C, et al. J Immunol Res. 2019 Feb 6;2019:8795673. doi: 10.1155/2019/8795673. eCollection 2019. J Immunol Res. 2019. PMID: 30882007 Free PMC article. Review.

8

CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γ_c cytokine stimulation via PI3K/mTOR axis.

Capuano C, Pighi C, Maggio R, Battella S, Morrone S, Palmieri G, Santoni A, Klein C, Galandrini R. Capuano C, et al. Cancer Immunol Immunother. 2020 Apr;69(4):501-512. doi: 10.1007/s00262-020-02482-2. Epub 2020 Jan 16. Cancer Immunol Immunother. 2020. PMID: 31950225 Free PMC article.

9

Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs.

Capuano C, Pighi C, Battella S, De Federicis D, Galandrini R, Palmieri G. Capuano C, et al. Cancers (Basel). 2021 May 20;13(10):2500. doi: 10.3390/cancers13102500. Cancers (Basel). 2021. PMID: 34065399 Free PMC article. Review.

10

(Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition.

Capuano C, Pighi C, Battella S, Pulcinelli F, Santoro C, Ferretti A, Turriziani O, De Federicis D, Fionda C, Sciumè G, Galandrini R, Palmieri G. Capuano C, et al. Biomedicines. 2022 Mar 8;10(3):625. doi: 10.3390/biomedicines10030625. Biomedicines. 2022. PMID: 35327427 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page